Michael O. Breckwoldt

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

May, 2025

Michael O. Breckwoldt

May 2, 2025, 09:29 | Insight

Francisco J Esteva shares POLAR study results on chemotherapy-induced neuropathy

Francisco J Esteva, Chief of the Division of Hematology and Medical Oncology at Lenox Hill…

All: 1 Posts: 1 - 100

'

HYPO-RT-PC Phase III trial: Two-Week Radiotherapy Proven as Safe and Effective as Eight-Week Course for Prostate Cancer, After 10-Year Follow-Up

'

TOPGEAR trial at ESTRO 2025: Preoperative Chemoradiotherapy for Resectable Gastric Cancer

'

NIVOPOSTOP (GORTEC 2018-01): A Phase III Trial of Adjuvant Nivolumab in High-Risk Resected Head and Neck Squamous Cell Carcinoma

'

Bianca Balti: The Supermodel’s Brave Battle with Ovarian Cancer

'

NCD Frontlines with Saunthari Somasundaram | A New OncoDaily Podcast – Coming Soon

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023